CME Group Inc. (CME)
CME Group: Buy Affirmed Again, As Market Demand And Strong Margins Win
CME Group gets rated buy again, reaffirming my last rating. The firm is growing new products, markets, and users, as well as having achieved profit margins beating its sector and key peers, and cashflow growth. Two key business segments of operating exchanges, as well as providing market data to subscribers, have seen demand growth.
If I Could Only Buy 2 Dividend Stocks Right Now - These Would Be It
Inflation isn't going away. In fact, it may soon be fueled deliberately. That makes owning hard assets and top-tier dividend stocks essential. I've identified two stocks that thrive in this new reality, each built to handle inflation, deliver income, and offer long-term upside. These aren't random picks. They're special. If I could buy only two dividend stocks for what's coming, I'd seriously consider these.
Capitalize on Volatility: 3 Finance Stocks Thriving in 2025
Markets may hate uncertainty, but in 2025, they seem to love volatility. Despite cloudy and, at times, contradictory economic indicators, the NASDAQ and S&P 500 indices reached all-time highs to close out the second quarter.
3 Bitcoin-Centric Stocks in Focus Amid Ongoing Geopolitical Tensions
As Bitcoin holds above $100K despite global tensions, CME, Visa and PayPal emerge as crypto plays with 2025 upside.
2 Dividend Stocks I'd Marry If I Could
Markets are chaotic, headlines rule, and short-term forecasts are pointless. That's why I focus on long-term dividend investing with wide-moat stocks. In this environment, I'm doubling down on two of my favorite dividend stocks, which are built for uncertainty, strong cash flow, and dependable dividends. With long-term conviction, I keep using market weakness to add to these holdings. I'm sticking to this playbook for compounding success.
Best Cryptocurrency and Blockchain Stocks to Power Up Your Portfolio
Here, we discuss three stocks, CME, MARA and MSTR, which are well-poised to benefit from the growing proliferation of Bitcoin and other cryptocurrencies.
CME Group: Should Investors Chase Momentum Or Wait For A Dip?
CME Group remains a buy, despite a premium valuation, thanks to strong cash flow, market dominance, and a resilient business model. The company's recurring revenue, high margins, and growth across product lines justify its higher multiple and support 20% upside potential. Risks include regulatory changes, tech migration challenges, legal headwinds, and potential market slowdowns, but these are manageable for long-term investors.
CME (CME) Up 7.1% Since Last Earnings Report: Can It Continue?
CME (CME) reported earnings 30 days ago. What's next for the stock?
CME Group vs. Intercontinental: Which Exchange Stock is a Better Buy?
Though both CME and ICE are Buy-rated stocks, let's find out which exchange stock is a better investment to generate sizable returns.
Is CME Group (CME) Stock Outpacing Its Finance Peers This Year?
Here is how CME Group (CME) and ACNB (ACNB) have performed compared to their sector so far this year.
CME Hits 52-Week High: Time to Buy Despite Expensive Valuation?
Let us delve deeper to find out what to do with CME stock now.
Is CME Group (CME) Outperforming Other Finance Stocks This Year?
Here is how CME Group (CME) and Banco De Chile (BCH) have performed compared to their sector so far this year.
